| Previous Close | 4.83 |
| Open | 4.92 |
| Day High | 5.01 |
| Day Low | 4.85 |
| 52-Week High | 11.3 |
| 52-Week Low | 4.37 |
| Volume | 283,379 |
| Average Volume | 305,248 |
| Market Cap | 131.35M |
| PE | -2.45 |
| EPS | -2.02 |
| Moving Average 50 Days | 6.39 |
| Moving Average 200 Days | 7.72 |
| Change | 0.12 |
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
GlobeNewswire Inc.
Mar 02, 2026 1:30 PM GMT
MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced t
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026
GlobeNewswire Inc.
Jan 29, 2026 9:10 PM GMT
MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu